Alumend

Novel therapy will have room to grow at USD Discovery District

After two decades in development, a unique drug and device combination for a hard-to-treat disease will have a new home at the USD Discovery District.

1 year ago

Biopharmaceutical companies to locate at USD Discovery District

SAB Biotherapeutics and Alumend are the first companies to announce plans to locate at the USD Discovery District.

1 year ago

Companies to watch: These three biotech startups are in clinical trials

Three companies with a huge range of promising technologies will be part of a panel discussion June 15 at Breakthrough, an annual summit and banquet for South Dakota Biotech.

2 years ago

Groundbreaking Avera-backed therapy cleared for clinical trials

A technology to treat peripheral vascular disease that was developed in a Sioux Falls lab and acquired by Avera has been approved for clinical trials.

2 years ago

News Tip

Have a business news item to share with us?

Scroll to top